Minaris Regenerative Medicine GmbH

Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. They offer high value clinical and commercial manufacturing services, development solutions, and technologies. They are pioneers in the field with more than 20 years’ experience providing outstanding quality and reliability. There facilities in North America, Europe, and Asia allow them to supply patients worldwide with life-changing therapies. Minaris Regenerative Medicine is wholly owned by Showa Denko Materials Co., Ltd.